Stay updated on PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial
Sign up to get notified when there's something new on the PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial page.

Latest updates to the PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial page
- CheckyesterdayChange DetectedA banner announces NIH website transition updates and says that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.SummaryDifference1%

- Check7 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.3%

- Check14 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.3%

- Check28 days agoChange DetectedA 403 Forbidden error page was added, including the HTML snippet and a 403 title, indicating that access to the study record is blocked and a Home link is provided in the footer. This reflects an access-control issue rather than a content update.SummaryDifference0.5%

- Check35 days agoChange DetectedA revision tag (Revision: v3.7.0) was added, and a large set of metadata terms and PubMed-related sections were removed from the record, affecting auxiliary information and indexing rather than the study's essential details.SummaryDifference18%

- Check56 days agoChange DetectedThe study record adds a U.S. NIH grant/contract identifier and updates the page revision to v3.6.6. The previous revision tag v3.6.5 is removed.SummaryDifference0.1%

Stay in the know with updates to PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial page.